The 96 women, averaging 71 years old were not taking any calcium or Vitamin D supplements. Using 7-day food diaries the researchers divided them into low (less than 300 mg/day) or high (greater than 300 mg/day) caffeine intake levels. BMD at the spine, hip, and three other sites was measured, and each subject's VDR genotype was determined. Calculation of the percent change in BMD during the 3-year longitudinal study showed that a caffeine intake of more than 300 mg/day was associated with a higher rate of bone loss at most of the skeletal sites in the spine, although the difference was only significant in subjects carrying the homozygous tt genotype of VDR. Women in the high caffeine category with the tt genotype lost bone density over 3years, compared with no change in bone density the tt women in the low caffeine group.
Though the number of women with the tt genotype was relatively small (6 in the low caffeine group and 5 in the high caffeine group), these findings identify caffeine as a dietary factor, which can alter one's genetic predisposition toward osteoporosis. An editorial by Massey stresses that moderate caffeine ingestion-less than 16 ounces of brewed coffee per day or 32 ounces of brewed tea-is not associated with increased bone loss. Until it is practical to determine each person's VDR genotype, physicians should recommend both adequate dietary calcium and moderate caffeine consumption for their elderly patients.
Rapuri, Prema B, et al. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 2001;74:694-700.
Massey, Linda K. Is caffeine a risk factor for bone loss in the elderly? Am J Clin Nutr 2001;74:569-70.
This media release is provided by The American Society for Clinical Nutrition to provide current information on nutrition-related research. This information should not be construed as medical advice. If you have a medical concern, consult your doctor. To see the complete text of this article, please go to: